Erika Svensson
- Office: Uppsala
- Position: Partner | Advokat
- Areas: Corporate finance Life Sciences
Background
- 2017 Member of the Swedish Bar Association
- 2013– Lindahl law firm
- 2013 Uppsala University, LL.M.
- 2012–2013 EUCOTAX Wintercourse, Participant
Contact
Related
- 5/8/2023 1:54:02 PM Lindahl acted as legal advisor to Corline Biomedical
- 4/24/2023 10:38:46 AM Digital meetings in companies and associations might be possible next year
- 4/24/2023 10:38:28 AM New judgement concerning compilation of insider list
- 3/21/2023 4:08:06 PM Lindahl was legal counsel to Senzime AB (publ) in connection with the company’s rights issue
- 3/16/2023 3:50:55 PM The obligation to register transactions – more legal entities to be regarded as closely associated parties
- 2/20/2023 12:40:23 PM The Board of Directors’ information in connection with a directed share issue did not conform to good practice
- 2/20/2023 10:40:07 AM It’s time to prepare the annual general meeting!
- 2/17/2023 5:39:47 PM Listing Act: The European Commission proposes a simplification of prospectus regulations and the Market Abuse Regulation (MAR)
- 11/23/2022 1:47:07 PM Lindahl advisor to HPSolartech in connection with Omnes Capital’s investment in the company
- 11/16/2022 2:49:56 PM Lindahl advises Nanologica AB (publ) in connection with rights issue
- 8/10/2022 12:09:19 PM Lindahl advisor in connection with Broviken becoming principal owner of Corplus
- 7/18/2022 9:33:08 AM Lindahl advisor in connection with sale of the construction company K360 to Håndverksgruppen
- 3/29/2022 4:30:15 PM Lindahl acted as legal advisor to Nanologica AB (publ) in connection with its listing on Nasdaq Stockholm
- 12/8/2021 10:14:34 AM Lindahl Has Represented Elon Group Holding in The Merge of Electra Gruppen and Elon Group
- 9/3/2021 1:23:02 PM KitchenTime gets a new principal owner
- 6/9/2021 2:53:52 PM Lindahl assists Nanexa in a preferential rights issue
- 6/8/2021 2:56:48 PM Lindahl serves as advisor to Serendipity Partners in its acquisition of shares in Bluefish Pharmaceuticals
- 3/11/2021 3:01:44 PM Lindahl advisor when Maskin Väst gets new main owner
- 1/13/2021 11:31:53 AM Lindahl consultants for KAMIC Group’s acquisition of Eltecno
- 11/3/2020 9:12:12 AM Lindahl assists when Senzime out-licenses a medical device for the European market
- 10/9/2020 3:42:38 PM Lindahl legal advisors for acquisitions, flotations and public issues
- 10/5/2020 9:09:15 AM Lindahl advises LobSor
- 8/21/2020 12:23:02 PM Lindahl advises Eurocine Vaccines AB (publ) enters into an agreement with Spixia Biotechnology AB for the development and commercialization of Chlamydia vaccines
- 11/19/2019 12:31:29 PM Lindahl advises on sale of majority stake in software company
- 11/12/2019 2:37:30 PM Lindahl advisor in connection with the sale of Quixel to Epic Games
- 11/4/2019 12:55:15 PM Lindahl advises in connection with PledPharma’s listing on Nasdaq Stockholm
- 8/13/2019 3:09:27 PM Lindahl assists Calliditas Therapeutics AB (publ) in strategic in-licensing
- 10/12/2017 1:45:36 PM Lindahl advises in the listing of BioArctic on Nasdaq Stockholm
- 4/6/2017 1:42:28 PM Lindahl assists in Miklagruppen’s acquisition of Lundqvist Bil and Burlin Motor
